Therefore, despite inhibiting PI3K/Akt, Ding-Chuan-Tang's anti-inflammatory and antioxidant effects in COPD are partially mediated through Nrf2 upregulation, further underscoring the therapeutic potential of targeting Nrf2 activation for COPD management. This evidence concerns the gene AKT1 and chronic obstructive pulmonary disease.